
Rapastinel acetate
CAS No. 491872-39-0
Rapastinel acetate ( Rapastinel acetate (117928-94-6 Free base) )
产品货号. M28008 CAS No. 491872-39-0
Rapastinelacetate 是 N-甲基-D-天冬氨酸 (NMDA) 受体的调节剂和甘氨酸位点的部分激动剂,具有持久的抗抑郁作用。
纯度: >98% (HPLC)






规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥3540 | 有现货 |
![]() ![]() |
10MG | ¥5233 | 有现货 |
![]() ![]() |
25MG | ¥7995 | 有现货 |
![]() ![]() |
50MG | ¥11178 | 有现货 |
![]() ![]() |
100MG | ¥15066 | 有现货 |
![]() ![]() |
500MG | ¥30132 | 有现货 |
![]() ![]() |
1G | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称Rapastinel acetate
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Rapastinelacetate 是 N-甲基-D-天冬氨酸 (NMDA) 受体的调节剂和甘氨酸位点的部分激动剂,具有持久的抗抑郁作用。
-
产品描述Rapastinel acetate is a modulator of N-methyl-D-aspartate (NMDA) receptor and a partial agonist of glycine site long-lasting antidepressant effects.(In Vivo):Rapastinel acetate (3mg/kg; i.v.) facilitated long-term potentiation (LTP) 1day-2weeks but not 4weeks post-dosing. Biweekly dosing with Rapastinel acetate sustained this effect for at least 8weeks. A single dose of Rapastinel acetate increased the proportion of whole-cell NMDAR current contributed by NR2B-containing NMDARs in the hippocampus 1week post-dosing, which returned to baseline by 4weeks post-dosing.
-
体外实验——
-
体内实验——
-
同义词Rapastinel acetate (117928-94-6 Free base)
-
通路Membrane Transporter/Ion Channel
-
靶点NMDAR
-
受体Lipid|Mitochondria|iron chelator
-
研究领域——
-
适应症——
化学信息
-
CAS Number491872-39-0
-
分子量473.52
-
分子式C20H35N5O8
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESC(C)(O)=O.C(=O)([C@H]1N(C([C@H]([C@@H](C)O)N)=O)CCC1)N2[C@H](C(N[C@@H]([C@@H](C)O)C(N)=O)=O)CCC2
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Shachar DB, et al. Neuroprotection by a novel brain permeable iron chelator, VK-28, against 6-hydroxydopamine lession in rats. Neuropharmacology. 2004 Feb;46(2):254-63.
产品手册




关联产品
-
BDBM50597431
BDBM50597431 is an NMDA receptor modulator that may have can be used to study Alzheimer's disease and Parkinson's syndrome.
-
Indantadol HCl
Indantadol HCl (CHF-3381) is a NMDA antagonist and nonselective MAO inhibitor.
-
MDL 29951
MDL-29951 是一种新型甘氨酸拮抗剂,可在体外和体内激活 NMDA 受体(Ki=0.14 mM,[3H]甘氨酸结合)。